ArticlePharmaceutical research2023

Pre-clinical Formulation Development of an in situ Meglumine Salt of AZD5991: A Novel Macrocyclic Mcl-1 Inhibitor.

Wenzhan Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.